A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer&#39;s disease.

Elayta (CT1812) - Cognition Therap

http://www.ncbi.nlm.nih.gov/pubmed/38273408

Adam P Mecca; Anthony O Caggiano; Christopher H van Dyck; Hugh H Bartlett; Mary E Hamby; Michael Grundman; Nina G Diepenbrock; Richard E Carson; Ryan S O'Dell; Susan M Catalano; Yiyun Huang

Jan 26, 2024